Skip to main content
Terug
Watch Compare

agilon health, inc.

Datakwaliteit: 100%
AGL
NYSE Services Health Services
€ 19,02
▼ € 0,82 (-4,13%)
Marktkapitalisatie: 329,30 M
Prijs
€ 19,83
Marktkapitalisatie
329,30 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 34,12% annually over 5 years — strong growth
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -119,01 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 36,23%
Capital efficient — spends only 0,22% of revenue on capex

Groei

Revenue Growth (5Y)
34,12%
Boven sectorgemiddelde (3,76%)
Revenue (1Y)-2,11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-109,47%
Onder sectorgemiddelde (-15,74%)
ROIC-89,24%
Net Margin-6,60%
Op. Margin-7,81%

Veiligheid

Debt / Equity
0,00
Onder sectorgemiddelde (0,39)
Current Ratio1,08
Interest Coverage-69,75

Waardering

PE (TTM)
-0,84
Boven sectorgemiddelde (-1,17)
P/B Ratio1,08
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -0,8 -1,2
P/B 1,1 1,4
ROE % -109,5 -15,7
Net Margin % -6,6 -18,3
Rev Growth 5Y % 34,1 3,8
D/E 0,0 0,4

ETFs Holding This Stock

FYLD FYLD
0,66% weight
NIXT logo NIXT Research Affiliates Deletions ETF
0,57% weight
DEEF logo DEEF Xtrackers FTSE Developed ex US Multifactor ETF
0,28% weight
VIDI logo VIDI Vident International Equity Strategy ETF
0,27% weight
FLAU logo FLAU Franklin FTSE Australia ETF
0,25% weight
GCSSX GCSSX
0,18% weight
GDSRX GDSRX
0,18% weight
GCSIX GCSIX
0,18% weight
GCSAX GCSAX
0,18% weight
GCSCX GCSCX
0,18% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -2,11% Revenue Growth (3Y) 17,24%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 34,12% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5,93 B Net Income (TTM) -391,35 M
ROE -109,47% ROA -23,65%
Gross Margin N/A Operating Margin -7,81%
Net Margin -6,60% Free Cash Flow (TTM) -119,01 M
ROIC -89,24% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 1,08
Interest Coverage -69,75 Asset Turnover 3,59
Working Capital 98,15 M Tangible Book Value 206,69 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,84 Forward P/E N/A
P/B Ratio 1,08 P/S Ratio 0,06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -36,14%
Market Cap 329,30 M Enterprise Value 157,62 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 357,25
FCF / Share -7,17 OCF / Share -6,37
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,22% FCF Conversion 30,41%
SBC-Adj. FCF -171,86 M Growth Momentum -36,23

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5,93 B 6,06 B 4,32 B 2,71 B 1,83 B
Net Income -391,35 M -260,15 M -262,60 M -106,55 M -406,49 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -463,24 M -292,13 M -232,13 M -120,43 M -393,95 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 28,59 M 24,46 M 20,16 M 13,77 M 14,67 M
Interest Expense 6,64 M 6,18 M 6,66 M 4,53 M 6,15 M
Income Tax 1,25 M 1,45 M 791.000,0 1,64 M 886.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,27 B 1,73 B 1,74 B 1,70 B 1,59 B
Total Liabilities 1,14 B 1,26 B 1,08 B 656,86 M 494,66 M
Shareholders' Equity 126,73 M 470,95 M 661,84 M 1,04 B 1,09 B
Total Debt 34,99 M 34,90 M 38,56 M 43,75 M 48,75 M
Cash & Equivalents 173,71 M 188,23 M 107,57 M 497,07 M 1,04 B
Current Assets 1,10 B 1,46 B 1,48 B 1,45 B 1,37 B
Current Liabilities 1,08 B 1,15 B 977,16 M 535,09 M 356,96 M